Insights Ahead: Pacira BioSciences's Quarterly Earnings
Pacira BioSciences (NASDAQ:PCRX) will release its quarterly earnings report on Tuesday, 2025-08-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Pacira BioSciences to report an earnings per share (EPS) of $0.62.
Pacira BioSciences bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Overview of Past Earnings
In the previous earnings release, the company beat EPS by $0.02, leading to a 0.84% increase in the share price the following trading session.
Here's a look at Pacira BioSciences's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.60 | 0.83 | 0.70 | 0.70 |
| EPS Actual | 0.62 | 0.91 | 0.79 | 0.89 |
| Price Change % | 1.0% | -5.0% | 0.0% | 6.0% |
Tracking Pacira BioSciences's Stock Performance
Shares of Pacira BioSciences were trading at $22.07 as of August 01. Over the last 52-week period, shares are up 4.95%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Pacira BioSciences visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
